Compared to SSc-nonPAH, SSc-PAH patients had higher IL-6, IL-13, IL-22, IL-32, TGF-β2, and TNF-α levels and lower IL-4 and TGF-β1 levels [36,37,158,192,193,194,195,196]. This evidence concerns the gene IL6 and systemic sclerosis.